ScholarGate
Assistant

Comparer des méthodes

Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.

Critères diagnostiques Rome IV du syndrome de l'intestin irritable×Questionnaire abrégé sur les maladies inflammatoires de l'intestin×
DomaineGastro-entérologieGastro-entérologie
FamilleProcess / pipelineProcess / pipeline
Année d'origine20162004
Auteur d'origineRome Foundation (multinational expert consensus)Guyonnet, D., Chassany, O., Ducroc, R., et al.
TypeDiagnostic CriteriaSelf-report
Source fondatriceMearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
AliasRome IV IBS, Rome CriteriaIBDQ-32, Short IBDQ
Apparentées44
RésuméThe Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateJeu de données
  1. v1
  2. 1 Sources
  3. PUBLISHED
  1. v1
  2. 1 Sources
  3. PUBLISHED

Aller à la recherche Télécharger les diapositives

ScholarGateComparer des méthodes: Rome IV Irritable Bowel Syndrome Criteria · Short Inflammatory Bowel Disease Questionnaire. Consulté le 2026-06-20 sur https://scholargate.app/fr/compare